Shares of Euroseas Ltd. (NASDAQ:ESEA) Explode Following the Financial Results for the Nine-Month Period and Quarter Ended September 30, 2016

Shares of Euroseas Ltd. (NASDAQ:ESEA) Explode Following the Financial Results for the Nine-Month Period and Quarter Ended September 30, 2016

Owner and operator of drybulk and container carrier vessels and provider of seaborne transportation, Euroseas Ltd. (NASDAQ:ESEA), announces Q3, 2016 financial reports. MAROUSSI, ATHENS, GREECE–(Marketwired – Nov 10, 2016) – Euroseas Ltd. (NASDAQ : ESEA ), an owner and operator of drybulk and container carrier vessels and provider of seaborne transportation for drybulk and containerized cargoes, announced today its results for the three and nine month periods ended September 30, […]

Read More ˃
Top Image Systems, Ltd. (NASDAQ:TISA) Third Quarter Earnings Results Release Scheduled for Tuesday, November 15, 2016.  How Will the Market React?

Top Image Systems, Ltd. (NASDAQ:TISA) Third Quarter Earnings Results Release Scheduled for Tuesday, November 15, 2016. How Will the Market React?

Global innovator of intelligent content processing solutions, Top Image Systems, Ltd. (NASDAQ:TISA), announces that the results of their Q3 2016 earnings will be released on November 15th, 2016. TEL AVIV, Israel and PLANO, Texas, Nov. 02, 2016 (GLOBE NEWSWIRE) — Top Image Systems Ltd. (TISA) a global innovator of intelligent content processing solutions, today announced that the Company will be releasing its results for the third quarter of 2016 on […]

Read More ˃
Shares of Signal Genetics, Inc. (NASDAQ:SGNL) Up After Signing Merger with miRagen Therapeutics

Shares of Signal Genetics, Inc. (NASDAQ:SGNL) Up After Signing Merger with miRagen Therapeutics

Molecular diagnostics company, Signal Genetics, Inc. (NASDAQ:SGNL), announces signing of merger with privately-held biopharmaceutical company, Miragen Therapeutics, Inc. Signal Genetics, Inc. (SGNL) (“Signal”) and Miragen Therapeutics, Inc. (“miRagen”), a privately-held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of miRagen are currently estimated to become holders of approximately 96% of Signal’s outstanding common stock on a fully-diluted basis. The proposed merger […]

Read More ˃
pSivida, Corp. (NASDAQ:PSDV) Announces Release Date and Conference Call Information for First Quarter Fiscal Year 2017 Financial Results

pSivida, Corp. (NASDAQ:PSDV) Announces Release Date and Conference Call Information for First Quarter Fiscal Year 2017 Financial Results

Leader in the development of sustained release drug delivery products, pSivida, Corp. (NASDAQ:PSDV), announced that its financial results for Q1 will be released on Monday, November 7th. WATERTOWN, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) — pSivida Corp. (PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for treating eye diseases, today announced its financial results for the first quarter of fiscal year 2017 will be […]

Read More ˃
Zion Oil & Gas, Inc. (NASDAQ:ZN) Reveals New, Simplified Stock Unit Option Program.  How Will the Market Respond?

Zion Oil & Gas, Inc. (NASDAQ:ZN) Reveals New, Simplified Stock Unit Option Program. How Will the Market Respond?

Oil and gas company, Zion Oil & Gas, Inc. (NASDAQ:ZN), announces a new Unit Option program under its Dividend Reinvestment and Common Stock Purchase Plan. DALLAS and CAESAREA, Israel, Nov. 01, 2016 (GLOBE NEWSWIRE) — Zion Oil & Gas, Inc. (NASDAQ:ZN) announces its new Unit Option program under its Dividend Reinvestment and Common Stock Purchase Plan (DSPP). “We are excited to launch this new Unit Option Program, which if successful, […]

Read More ˃
Shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) Continue to Plummet Days After Trial Failure

Shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) Continue to Plummet Days After Trial Failure

Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX)’s stock price continues its downward spike following their Phase 3 trial failure.  Several blogs have weighed in. LONDON, UK / ACCESSWIRE / October 26, 2016 / Active Wall St. blog coverage looks at the headline from Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) as the company’s stock price plunged 78% on October 25th, 2016, following news that the Phase 3 trial of the drug maker’s treatment for diabetic […]

Read More ˃
Shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) Plummet 84% on Phase 3 Trial Failure

Shares of Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX) Plummet 84% on Phase 3 Trial Failure

Late stage pharmaceutical company focusing on diabetic foot ulcers, Dipexium Pharmaceuticals, Inc. (NASDAQ:DPRX), reports failures during the Phase 3 trial of its drug Locilex. Dipexium Pharmaceuticals Inc. (DPRX) stock plunged 84% on October 25 after the Nasdaq-listed company reported massive failures on the Phase 3 trial of its Locilex (pexiganan 0.8%) cream to treat diabetic foot ulcers. Dipexium traded as low as $1.95 per share during the pre-market session October […]

Read More ˃
Shares of Towerstream, Corp. (NASDAQ:TWER) Advance on News That Building Additions Projected to More Than Double in H2

Shares of Towerstream, Corp. (NASDAQ:TWER) Advance on News That Building Additions Projected to More Than Double in H2

Leading fixed-wireless fiber alternative company, Towerstream, Corp. (NASDAQ:TWER), announces that it will add 100 new buildings in Q4, bringing its on-net footprint to 437 total buildings. MIDDLETOWN, R.I., Oct. 25, 2016 (GLOBE NEWSWIRE) — Towerstream Corporation (TWER) (the “Company”), a leading fixed-wireless fiber alternative company, announced today that it expects to add 100 new buildings to its On-Net footprint in Q4 to 437 total buildings. This is more than double […]

Read More ˃
Shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) Bump After News of $5,000,000 Public Offering of Common Stock Priced Out

Shares of Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) Bump After News of $5,000,000 Public Offering of Common Stock Priced Out

Pharmaceutical company, Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR), announces pricing of $5 million public offering of common stock. LOS ANGELES, CA–(Marketwired – Oct 26, 2016) – Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR ) a pharmaceutical company developing novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases with its lead product, RP-G28, being developed for the treatment of lactose intolerance, today announced the pricing of an underwritten public […]

Read More ˃
Shares of Unilife, Corp. (NASDAQ:UNIS) Vault Upon Announcement of Filing of 2016 10-K

Shares of Unilife, Corp. (NASDAQ:UNIS) Vault Upon Announcement of Filing of 2016 10-K

Developer and commercial supplier of injectable drug delivery systems, Unilife, Corp. (NASDAQ:UNIS), announced that it has filed its annual report on from 10-K for fiscal year 2016 YORK, Pa., Oct. 24, 2016 /PRNewswire/ — Unilife Corporation (“Unilife” or “Company”) (NASDAQ: UNIS; ASX: UNS) today announced that it has filed its Annual Report on Form 10-K for fiscal year 2016. In addition, the Company filed its Quarterly Report on Form 10-Q […]

Read More ˃